Accuray Incorporated Logo

Accuray Incorporated

ARAY

(0.0)
Stock Price

1,90 USD

-1.62% ROA

-28.12% ROE

-40.68x PER

Market Cap.

278.111.853,00 USD

402.21% DER

0% Yield

-3.25% NPM

Accuray Incorporated Stock Analysis

Accuray Incorporated Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Accuray Incorporated Fundamental Stock Analysis
# Analysis Rating
1 ROE

Negative ROE (-17.92%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

2 ROA

The stock's ROA (-2.2%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

3 PBV

The stock's elevated P/BV ratio (4.6x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

4 DER

The company has a high debt to equity ratio (382%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-64) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Accuray Incorporated Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Accuray Incorporated Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Accuray Incorporated Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Accuray Incorporated Revenue
Year Revenue Growth
2002 19.354.000
2003 2.710.000 -614.17%
2004 19.569.000 86.15%
2005 22.377.000 12.55%
2006 52.897.000 57.7%
2007 140.452.000 62.34%
2008 210.381.000 33.24%
2009 233.598.000 9.94%
2010 221.625.000 -5.4%
2011 222.284.000 0.3%
2012 409.223.000 45.68%
2013 315.974.000 -29.51%
2014 369.419.000 14.47%
2015 379.801.000 2.73%
2016 398.800.000 4.76%
2017 383.414.000 -4.01%
2018 404.897.000 5.31%
2019 418.785.000 3.32%
2020 382.928.000 -9.36%
2021 396.289.000 3.37%
2022 429.909.000 7.82%
2023 447.605.000 3.95%
2024 415.568.000 -7.71%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Accuray Incorporated Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 5.844.000 100%
2004 0 0%
2005 11.655.000 100%
2006 17.788.000 34.48%
2007 26.775.000 33.56%
2008 32.880.000 18.57%
2009 35.992.000 8.65%
2010 31.523.000 -14.18%
2011 41.687.000 24.38%
2012 87.114.000 52.15%
2013 66.197.000 -31.6%
2014 53.724.000 -23.22%
2015 55.752.000 3.64%
2016 56.652.000 1.59%
2017 49.921.000 -13.48%
2018 57.251.000 12.8%
2019 56.493.000 -1.34%
2020 49.784.000 -13.48%
2021 52.729.000 5.59%
2022 57.752.000 8.7%
2023 57.129.000 -1.09%
2024 56.052.000 -1.92%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Accuray Incorporated General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 23.915.000 100%
2008 32.280.000 25.91%
2009 36.223.000 10.89%
2010 35.472.000 -2.12%
2011 56.657.000 37.39%
2012 58.598.000 3.31%
2013 57.726.000 -1.51%
2014 45.335.000 -27.33%
2015 46.379.000 2.25%
2016 50.122.000 7.47%
2017 43.766.000 -14.52%
2018 48.136.000 9.08%
2019 49.577.000 2.91%
2020 40.966.000 -21.02%
2021 41.723.000 1.81%
2022 44.391.000 6.01%
2023 48.271.000 8.04%
2024 52.092.000 7.34%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Accuray Incorporated EBITDA
Year EBITDA Growth
2002 19.354.000
2003 -15.886.000 221.83%
2004 19.569.000 181.18%
2005 -22.803.000 185.82%
2006 -29.686.000 23.19%
2007 -1.914.000 -1450.99%
2008 6.754.000 128.34%
2009 -2.418.000 379.32%
2010 2.836.000 185.26%
2011 -20.174.000 114.06%
2012 -50.116.000 59.75%
2013 -80.655.000 37.86%
2014 -18.144.000 -344.53%
2015 -19.169.000 5.35%
2016 -4.873.000 -293.37%
2017 -9.823.000 50.39%
2018 -3.797.000 -158.7%
2019 583.000 751.29%
2020 11.868.000 95.09%
2021 22.235.000 46.62%
2022 8.148.000 -172.89%
2023 2.382.000 -242.07%
2024 16.368.000 85.45%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Accuray Incorporated Gross Profit
Year Gross Profit Growth
2002 19.354.000
2003 -317.000 6205.36%
2004 19.569.000 101.62%
2005 11.262.000 -73.76%
2006 25.405.000 55.67%
2007 80.039.000 68.26%
2008 106.952.000 25.16%
2009 115.290.000 7.23%
2010 104.018.000 -10.84%
2011 107.242.000 3.01%
2012 137.272.000 21.88%
2013 97.640.000 -40.59%
2014 142.800.000 31.62%
2015 145.402.000 1.79%
2016 158.713.000 8.39%
2017 141.341.000 -12.29%
2018 161.695.000 12.59%
2019 162.651.000 0.59%
2020 149.872.000 -8.53%
2021 159.507.000 6.04%
2022 159.955.000 0.28%
2023 153.960.000 -3.89%
2024 157.972.000 2.54%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Accuray Incorporated Net Profit
Year Net Profit Growth
2002 0
2003 -15.840.000 100%
2004 -11.696.000 -35.43%
2005 -25.189.000 53.57%
2006 -33.694.000 25.24%
2007 -5.616.000 -499.96%
2008 5.383.000 204.33%
2009 609.000 -783.91%
2010 2.841.000 78.56%
2011 -26.682.000 110.65%
2012 -72.042.000 62.96%
2013 -103.219.000 30.2%
2014 -35.448.000 -191.18%
2015 -40.209.000 11.84%
2016 -25.504.000 -57.66%
2017 -29.579.000 13.78%
2018 -23.899.000 -23.77%
2019 -16.430.000 -45.46%
2020 3.156.000 620.6%
2021 -6.311.000 150.01%
2022 -5.347.000 -18.03%
2023 -9.280.000 42.38%
2024 -11.876.000 21.86%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Accuray Incorporated Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 -1 100%
2004 -1 0%
2005 -2 0%
2006 -2 50%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 -1 100%
2013 -1 0%
2014 0 0%
2015 -1 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Accuray Incorporated Free Cashflow
Year Free Cashflow Growth
2005 11.766.000
2006 11.903.000 1.15%
2007 4.367.000 -172.57%
2008 -23.019.000 118.97%
2009 -12.278.000 -87.48%
2010 -10.203.000 -20.34%
2011 8.381.000 221.74%
2012 -49.048.000 117.09%
2013 -81.535.000 39.84%
2014 -11.585.000 -603.8%
2015 -27.178.000 57.37%
2016 25.472.000 206.7%
2017 -5.744.000 543.45%
2018 11.722.000 149%
2019 -33.952.000 134.53%
2020 -5.197.000 -553.3%
2021 36.192.000 114.36%
2022 -7.117.000 608.53%
2023 2.858.000 349.02%
2024 -9.683.000 129.52%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Accuray Incorporated Operating Cashflow
Year Operating Cashflow Growth
2005 18.015.000
2006 25.505.000 29.37%
2007 11.597.000 -119.93%
2008 -17.989.000 164.47%
2009 -8.046.000 -123.58%
2010 -5.073.000 -58.6%
2011 12.403.000 140.9%
2012 -38.279.000 132.4%
2013 -66.177.000 42.16%
2014 346.000 19226.3%
2015 -16.733.000 102.07%
2016 33.538.000 149.89%
2017 -380.000 8925.79%
2018 18.331.000 102.07%
2019 -29.641.000 161.84%
2020 -1.469.000 -1917.77%
2021 38.512.000 103.81%
2022 -2.400.000 1704.67%
2023 15.539.000 115.45%
2024 -8.591.000 280.88%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Accuray Incorporated Capital Expenditure
Year Capital Expenditure Growth
2005 6.249.000
2006 13.602.000 54.06%
2007 7.230.000 -88.13%
2008 5.030.000 -43.74%
2009 4.232.000 -18.86%
2010 5.130.000 17.5%
2011 4.022.000 -27.55%
2012 10.769.000 62.65%
2013 15.358.000 29.88%
2014 11.931.000 -28.72%
2015 10.445.000 -14.23%
2016 8.066.000 -29.49%
2017 5.364.000 -50.37%
2018 6.609.000 18.84%
2019 4.311.000 -53.31%
2020 3.728.000 -15.64%
2021 2.320.000 -60.69%
2022 4.717.000 50.82%
2023 12.681.000 62.8%
2024 1.092.000 -1061.26%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Accuray Incorporated Equity
Year Equity Growth
2002 -23.632.000
2003 -33.048.000 28.49%
2005 -56.172.000 41.17%
2006 -80.855.000 30.53%
2007 125.443.000 164.46%
2008 130.763.000 4.07%
2009 153.902.000 15.03%
2010 170.076.000 9.51%
2011 229.775.000 25.98%
2012 195.625.000 -17.46%
2013 106.835.000 -83.11%
2014 98.548.000 -8.41%
2015 75.780.000 -30.04%
2016 59.660.000 -27.02%
2017 46.533.000 -28.21%
2018 48.632.000 4.32%
2019 49.871.000 2.48%
2020 62.786.000 20.57%
2021 68.840.000 8.79%
2022 53.189.000 -29.43%
2023 53.659.000 0.88%
2024 50.944.000 -5.33%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Accuray Incorporated Assets
Year Assets Growth
2002 11.925.000
2003 32.347.000 63.13%
2005 86.860.000 62.76%
2006 138.623.000 37.34%
2007 332.109.000 58.26%
2008 295.004.000 -12.58%
2009 274.386.000 -7.51%
2010 263.184.000 -4.26%
2011 455.784.000 42.26%
2012 473.170.000 3.67%
2013 475.929.000 0.58%
2014 495.188.000 3.89%
2015 469.971.000 -5.37%
2016 469.033.000 -0.2%
2017 406.464.000 -15.39%
2018 378.727.000 -7.32%
2019 438.181.000 13.57%
2020 490.078.000 10.59%
2021 480.098.000 -2.08%
2022 472.849.000 -1.53%
2023 479.214.000 1.33%
2024 476.830.000 -0.5%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Accuray Incorporated Liabilities
Year Liabilities Growth
2002 35.557.000
2003 65.395.000 45.63%
2005 143.032.000 54.28%
2006 219.478.000 34.83%
2007 206.666.000 -6.2%
2008 164.241.000 -25.83%
2009 120.484.000 -36.32%
2010 93.108.000 -29.4%
2011 215.457.000 56.79%
2012 269.303.000 19.99%
2013 369.094.000 27.04%
2014 396.640.000 6.94%
2015 394.191.000 -0.62%
2016 409.373.000 3.71%
2017 359.931.000 -13.74%
2018 330.095.000 -9.04%
2019 388.310.000 14.99%
2020 427.292.000 9.12%
2021 411.258.000 -3.9%
2022 419.660.000 2%
2023 425.555.000 1.39%
2024 425.886.000 0.08%

Accuray Incorporated Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4.71
Net Income per Share
-0.07
Price to Earning Ratio
-40.68x
Price To Sales Ratio
0.61x
POCF Ratio
40.08
PFCF Ratio
-49.67
Price to Book Ratio
5.43
EV to Sales
0.89
EV Over EBITDA
46.92
EV to Operating CashFlow
58.84
EV to FreeCashFlow
-72.53
Earnings Yield
-0.02
FreeCashFlow Yield
-0.02
Market Cap
0,28 Bil.
Enterprise Value
0,41 Bil.
Graham Number
0.91
Graham NetNet
-2.24

Income Statement Metrics

Net Income per Share
-0.07
Income Quality
-1.02
ROE
-0.13
Return On Assets
-0.03
Return On Capital Employed
-0
Net Income per EBT
1.37
EBT Per Ebit
10.69
Ebit per Revenue
-0
Effective Tax Rate
-0.37

Margins

Sales, General, & Administrative to Revenue
0.11
Research & Developement to Revenue
0.13
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.34
Operating Profit Margin
-0
Pretax Profit Margin
-0.02
Net Profit Margin
-0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.07
Free CashFlow per Share
-0.06
Capex to Operating CashFlow
-1.81
Capex to Revenue
-0.03
Capex to Depreciation
-2.72
Return on Invested Capital
0.04
Return on Tangible Assets
-0.02
Days Sales Outstanding
62.07
Days Payables Outstanding
42.99
Days of Inventory on Hand
184.85
Receivables Turnover
5.88
Payables Turnover
8.49
Inventory Turnover
1.97
Capex per Share
-0.13

Balance Sheet

Cash per Share
0,80
Book Value per Share
0,53
Tangible Book Value per Share
-0.07
Shareholders Equity per Share
0.53
Interest Debt per Share
2.22
Debt to Equity
4.02
Debt to Assets
0.43
Net Debt to EBITDA
14.79
Current Ratio
1.66
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,09 Bil.
Invested Capital
4.02
Working Capital
0,13 Bil.
Intangibles to Total Assets
0.12
Average Receivables
0,08 Bil.
Average Payables
0,03 Bil.
Average Inventory
147563500
Debt to Market Cap
0.74

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Accuray Incorporated Dividends
Year Dividends Growth

Accuray Incorporated Profile

About Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

CEO
Ms. Suzanne Winter M.B.A.
Employee
1.024
Address
1310 Chesapeake Terrace
Sunnyvale, 94089

Accuray Incorporated Executives & BODs

Accuray Incorporated Executives & BODs
# Name Age
1 Mr. Jesse Chew
Senior Vice President, Chief Legal Officer & Company Secretary
70
2 Mr. John M. Dunn
Vice President, Chief Information & Security Officer
70
3 Mr. Juki Hozumi
President & GM of Japan Region
70
4 Ms. Suzanne Winter M.B.A.
President, Chief Executive Officer & Director
70
5 Mr. Sandeep Chalke
Senior Vice President & Chief Commercial Officer
70
6 Beth Kaplan
Public Relations Director
70
7 Ms. Melanie Gebauer
Vice President of Global Human Resources
70
8 Mr. Ali Pervaiz
Senior Vice President & Chief Financial Officer
70
9 Mr. Michael Hoge
Senior Vice President of Global Operations
70
10 Ms. Gina Corradetti
Vice President, Chief Accounting Officer, Principal Accounting Officer & Controller
70

Accuray Incorporated Competitors

Surmodics, Inc. Logo
Surmodics, Inc.

SRDX

(0.8)
AxoGen, Inc. Logo
AxoGen, Inc.

AXGN

(1.2)
Bioventus Inc. Logo
Bioventus Inc.

BVS

(0.8)
Cutera, Inc. Logo
Cutera, Inc.

CUTR

(2.0)
NuVasive, Inc. Logo
NuVasive, Inc.

NUVA

(1.0)
Paragon 28, Inc. Logo
Paragon 28, Inc.

FNA

(1.5)
SI-BONE, Inc. Logo
SI-BONE, Inc.

SIBN

(1.0)
Artivion, Inc. Logo
Artivion, Inc.

AORT

(0.5)
NeuroPace, Inc. Logo
NeuroPace, Inc.

NPCE

(0.5)
TELA Bio, Inc. Logo
TELA Bio, Inc.

TELA

(1.2)